ZERBAXA
Active substance: CEFTOLOZANE SULFATE, TAZOBACTAM SODIUM
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CEFTOLOZANE SULFATE 1 g/10mL, TAZOBACTAM SODIUM .5 g/10mL
United StatesActive
Marketing holder: Merck Sharp & Dohme LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CEFTOLOZANE SULFATE · 1 g/10mL
- TAZOBACTAM SODIUM · .5 g/10mL
Registration
- Registration number
- 67919-030
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 67919-030 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 67919-030 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 67919-030 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 67919-030 · Verified 2026-10-09 · open in source